Press release
Epilepsy Pipeline: Clinical Trials, Growth Prospects, Insights into Novel and Emerging Pipeline Therapies, Key Companies, and Treatment Landscape | DelveInsight
Epilepsy Pipeline
To know more about Epilepsy pipeline report, click here: https://www.delveinsight.com/report-store/epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the essential takeaways from the Epilepsy Pipeline report:
• DelveInsight's Epilepsy Pipeline analysis depicts the space with 70+ active players working to develop 70+ pipeline therapies.
• Major pharmaceutical companies are developing potential drug candidates to improve the Epilepsy treatment scenario, such as Otsuka Pharmaceutical Co. Ltd, Cerebral Therapeutics LLC, Marinus Pharmaceuticals, Xenon Pharmaceuticals, PTC Therapeutics, Eisai, Longboard Pharmaceuticals, Neurocrine Biosciences, and others.
• Key Epilepsy pipeline therapies such as OPC-214870, CT-010, Ganaxolone, XEN496, Vatiquinone E-2730, LP352, NBI 827104, and others are under investigation in different phases of clinical trials.
• In January 2021, Addex Therapeutics announced that its partner Janssen Pharmaceuticals had received FDA's Investigational New Drug (IND) approval to begin a Phase IIa proof of concept study with the selective metabotropic glutamate type 2 (mGlu2) receptor positive allosteric modulator (PAM), JNJ-40411813 (ADX71149), in patients with Epilepsy.
• In October 2020, PTC Therapeutics announced the initiation of a registration-directed Phase II/III clinical trial to evaluate vatiquinone (PTC743) in patients with mitochondrial Epilepsy, the highly morbid condition of refractory seizures in children with inherited mitochondrial disease.
Request for Epilepsy sample report to learn more about trends in specific geographies @ Epilepsy Emerging Therapies and Forecast: https://www.delveinsight.com/report-store/epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Epilepsy pipeline report lays down detailed profiles of the pipeline assets, inactive and dormant assets, comparative analysis of clinical and non-clinical stage Epilepsy products, comprehensive assessment of driving and restraining factors, and opportunities as well as risks in the Epilepsy pipeline landscape.
Epilepsy Overview
Epilepsy is a chronic neurological disorder characterized by frequent and recurring seizures leading to unusual behaviour. The primary cause of Epilepsy is not clear, but it is noted that any change in the nerve cells, neurons, and the brain resulting in abnormal signals can be the possible reason.
The most common symptom of Epilepsy includes seizures; however, additional symptoms like convulsion without fever, low consciousness, less awareness, loss of taste, smell, sight, hearing, etc., can also be present.
For further information about Epilepsy treatment and pipeline therapies, visit @ Epilepsy Pipeline Assessment: https://www.delveinsight.com/sample-request/epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Epilepsy Pipeline Drugs
• OPC-214870: Otsuka Pharmaceutical Co. Ltd
• CT-010: Cerebral Therapeutics LLC
• Ganaxolone: Marinus Pharmaceuticals
• XEN496: Xenon Pharmaceuticals
• Vatiquinone: PTC Therapeutics
• E-2730: Eisai
• NBI 827104: Neurocrine Biosciences
Request for Sample to know more @ Epilepsy Pipeline Analysis and Trends: https://www.delveinsight.com/sample-request/epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Epilepsy Therapeutics Assessment
The Epilepsy Pipeline report proffers an integral view of the Epilepsy emerging novel therapies segregated by Stage, Product Type, Route of Administration, Molecule Type, and Mechanism of Action.
By Product Type
• Mono
• Combination
• Mono/Combination
By Stage
• Discovery
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Pre-registration
By Route of Administration
• Subcutaneous
• Intravenous
• Oral
• Intraventricular
• Inhalation
By Molecule Type
• Gene therapy
• Stem cell therapy
• Small molecules
• Pyridines
By Mechanism of Action
• 4-aminobutyrate transaminase inhibitors
• GABA A receptor agonists
• KCNQ potassium channel agonists
• NQO1 modulators
• Serotonin receptor agonists
• T type calcium channel antagonists
By Targets
• GABA A receptor
• KCNQ potassium channel
• Serotonin receptor
• NQO1
• T type calcium channel
• Synaptic transmission
Scope of the Epilepsy Pipeline Report
• Coverage: Global
• Major Players: Otsuka Pharmaceutical Co. Ltd, Cerebral Therapeutics LLC, Marinus Pharmaceuticals, Xenon Pharmaceuticals, PTC Therapeutics, Eisai, Longboard Pharmaceuticals, Neurocrine Biosciences, and others.
• Key Epilepsy Pipeline Therapies: OPC-214870, CT-010, Ganaxolone, XEN496, Vatiquinone E-2730, LP352, NBI 827104, and others.
Dive deep into rich insights of Epilepsy novel and emerging drugs and their analysis @ Epilepsy Pipeline Emerging Novel Therapies: https://www.delveinsight.com/sample-request/epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1 Introduction
2 Executive Summary
3 Epilepsy: Overview
4 Epilepsy - Analytical Perspective In-depth Commercial Assessment
5 Pipeline Therapeutics
6 Late Stage Products (Phase III)
7 Late Stage Products (Phase II/III)
8 Mid Stage Products (Phase II)
9 Early Stage Products (Phase I)
10 Therapeutic Assessment
11 Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Epilepsy Key Companies
14 Epilepsy Key Products
15 Epilepsy- Unmet Needs
16 Epilepsy- Market Drivers and Barriers
17 Epilepsy- Future Perspectives and Conclusion
18 Epilepsy Analyst Views
19 Appendix
20 About DelveInsight
Get Epilepsy customized report @ Epilepsy Emerging Therapies: https://www.delveinsight.com/sample-request/epilepsy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Related Reports:
Adenoid Cystic Carcinoma Pipeline https://www.delveinsight.com/report-store/adenoid-cystic-carcinoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
"Adenoid Cystic Carcinoma Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Adenoid Cystic Carcinoma market. A detailed picture of the Adenoid Cystic Carcinoma pipeline landscape is provided, which includes the disease overview and Adenoid Cystic Carcinoma treatment guidelines.
Adenoid Cystic Carcinoma Epidemiology
https://www.delveinsight.com/report-store/adenoid-cystic-carcinoma-acc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's 'Adenoid Cystic Carcinoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Adenoid Cystic Carcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Diagnostic Imaging Equipment Market
https://www.delveinsight.com/report-store/diagnostic-imaging-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Diagnostic Imaging Equipment Market By Product (X-Ray Imaging Systems, Computed Tomography (CT) Scanners, Ultrasound Systems, Magnetic Resonance Imaging (MRI) Systems, Nuclear Imaging Systems, Mammography Systems, And Others), By Application (Cardiology, Oncology, Gastroenterology, Gynecology, And Other Applications), By End-User (Hospitals, Diagnostic Imaging Centres, And Others), by geography is expected to grow at a steady CAGR forecast till 2026 owing to rising technological advancement and increasing prevalence of chronic diseases.
Invasive Candidiasis Market
https://www.delveinsight.com/report-store/invasive-candidiasis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
"DelveInsight's 'Invasive Candidiasis Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Invasive Candidiasis and the historical and forecasted Invasive Candidiasis market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Sialidosis Market
https://www.delveinsight.com/report-store/sialidosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's "Sialidosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Sialidosis, historical and forecasted epidemiology as well as the Sialidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Filgrastim Biosimilar Insight
https://www.delveinsight.com/report-store/filgrastim-biosimilar-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's, "Filgrastim Biosimilar Insight, 2022," report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in the Filgrastim Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Pain Management Devices Market
https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Pain Management Devices Market By Type Of Devices (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices And Cryoablation Devices], And Others), By Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), By Geography is expected to grow at a steady CAGR Forecast till 2027
To know more about our Competitive Services, Click here:
https://www.delveinsight.com/consulting/competitive-intelligence-services?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epilepsy Pipeline: Clinical Trials, Growth Prospects, Insights into Novel and Emerging Pipeline Therapies, Key Companies, and Treatment Landscape | DelveInsight here
News-ID: 2715563 • Views: …
More Releases from DelveInsight Business Research
Vein Illumination Devices Market Trends Analysis, Growth Opportunities and Chall …
The Vein Illumination Devices market is being driven by a growing geriatric population as well as an increase in the number of surgical operations. The Vein Illumination Devices Market report from DelveInsight provides an in-depth analysis of the Vein Illumination Devices, as well as historical and forecasted market trends in the global market.
Vein Illumination Devices Overview
Vein illumination devices, also known as vein finders or vein viewers, are medical…
Systemic Scleroderma Market to Exhibit Rapid Growth Rate During the Forecast Per …
DelveInsight's "Systemic Scleroderma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Systemic Scleroderma, historical and forecasted epidemiology as well as the Systemic Scleroderma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Systemic Scleroderma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Systemic Scleroderma Market Forecast
https://www.delveinsight.com/sample-request/systemic-scleroderma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Adrenal crisis Market is Expected to Expand at a Healthy Growth Rate During the …
DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Congestive Heart Failure Market to Observe Impressive Growth During the Forecast …
DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Congestive Heart Failure, historical and forecasted epidemiology as well as the Congestive Heart Failure market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Congestive Heart Failure market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Congestive Heart Failure…
More Releases for Epilepsy
Epilepsy Market Synthesis and Opportunity Assessment 2030
Epilepsy - Market Insight, Epidemiology And Market Forecast -2030: This report delivers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Epilepsy market report provides current treatment practices, emerging drugs, Epilepsy market share of the individual therapies, current and forecasted Epilepsy market Size from 2017 to 2030 segmented…
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy …
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curve…
World Congress on Epilepsy and Neuronal Synchronization
Inculcate the latent knowledge in Epilepsy and Neuronal synchrony
May 14, 2018: Pulsus Group, host of World Congress on Epilepsy and Neuronal Synchronization, the Conference that discusses the Advanced diagnosis of Epilepsy.
Epilepsy 2018 slated during October 15- 16, 2015 at London, UK will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Neurology, Neuropsychiatry & Neuropathology fields across the world. The Epilepsy conference scientific…
Epilepsy Therapeutic Pipeline Market Review, 2026
Summary
Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain. It is one of the most common neurological conditions globally. Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered at least one epileptic seizure and is referred to a specialist, where a description of the…
Epilepsy - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Epilepsy - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the…
H2 Epilepsy Market Pipeline Review 2017
"The Report Epilepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H2 2017, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape.
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in…
